Yahoo Finance

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The Guardian Nigeria

Nigeria dumps 3G network as China routes Internet traffic via country

Fresh indications emerged yesterday that Nigeria is fast dropping the legacy 3G technology, and pivoting strategically ...
The Manila Times

Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results

ASHBURN, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late ...
Yahoo Finance

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

PARAMUS, N.J., April 21, 2026 (GLOBE NEWSWIRE)-- Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing disease-modifying therapies for rare pediatric LSDs, today ...
RACER

DRR’s fast start to Indy testing impresses Daly

Dreyer & Reinbold Racing hadn’t run an Indy car in nearly a year, but the first day of the Indy Open Test gave no indications ...

Latus Bio Announces $97 Million Series A Financing to Expand the Reach of Gene Therapy to Larger Populations

Latus Bio, Inc. (Latus), a biotechnology company engineering scalable gene therapies for broader patient populations, today ...

Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results

Filed Breakthrough Medicine Designation Application with Saudi FDA for QRX003 in Netherton Syndrome - Submitted Application to Japanese MHLW for Orphan Drug Designation (ODD) for QRX003; MHLW Confirme ...
Mena FN

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations For All Four Indications To Be Evaluated In The SOTERIA Basket Trial

(MENAFN- GlobeNewsWire - Nasdaq) PARAMUS, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing disease-modifying ...
Finanznachrichten

Polaryx Therapeutics, Inc.: Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

PARAMUS, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing disease-modifying therapies for rare pediatric LSDs, ...

FDA plans ultra-fast review of three psychedelic drugs following Trump directive

The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for ...